Healthcare Sector: Value Investing Analysis

About the Healthcare Sector

This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.

The Healthcare sector groups related businesses that share similar economic characteristics, market dynamics, and competitive forces. By analyzing stocks within this sector, you can compare companies on a more level playing field—making it easier to identify which businesses offer the best value for your investment dollars.

Understanding sector performance helps you evaluate whether individual stocks are cheap or expensive relative to their peers. A P/E ratio that looks high in one sector might be a bargain in another. This context is essential for value investors seeking to calculate realistic expected returns.

Healthcare Stocks: Value Analysis

Below are the stocks we track in the Healthcare sector, with key value investing metrics. If you have special knowledge about this sector, you have an advantage—use these metrics to find stocks that may be trading below their intrinsic value.

Discounted stocks in the index
Company Current Price Current Price Discount
10 years

(ALTH)
$0.00 none
Aethlon Medical
(AEMD)
$6.31 none
Viatris
(VTRS)
$17.13 none

(ONTY)
$0.00 none
West Pharmaceutical Services
(WST)
$366.60 none
STERIS plc
(STE)
$205.04 none
Avinger
(AVGR)
$0.00 none
Mannatech, Incorporated
(MTEX)
$7.51 none
DBV Technologies S.A.
(DBVT)
$12.35 none
Tilray
(TLRY)
$3.99 none
Globus Medical
(GMED)
$74.08 none
Aurinia Pharmaceuticals
(AUPH)
$16.90 none
Integer Holdings Corporation
(ITGR)
$126.28 none
Utah Medical Products
(UTMD)
$73.96 none
Arrowhead Pharmaceuticals
(ARWR)
$66.48 none
Trinity Biotech plc
(TRIB)
$7.23 none
Catalyst Pharmaceuticals
(CPRX)
$31.49 none
Baxter International
(BAX)
$22.80 18.5%
Imprimis Pharmaceuticals
(IMMY)
$0.00 none
Atossa Therapeutics
(ATOS)
$2.22 none
Abeona Therapeutics
(ABEO)
$5.57 none
Genetic Technologies Limited
(GENE)
$0.00 none
Lantheus Holdings
(LNTH)
$100.55 none
Ultragenyx Pharmaceutical
(RARE)
$14.50 none
Editas Medicine
(EDIT)
$2.70 none
Flexion Therapeutics
(FLXN)
$24.62 none
Heron Therapeutics
(HRTX)
$0.31 none
Alcon
(ALC)
$65.18 none
Marinus Pharmaceuticals
(MRNS)
$0.00 none
American Shared Hospital Services
(AMS)
$1.45 46.5%
OrganiGram Holdings
(OGI)
$1.05 none
Alkermes plc
(ALKS)
$46.71 none
AdvisorShares Vice ETF
(ACT)
$48.45 none
Johnson & Johnson
(JNJ)
$269.99 none
Ironwood Pharmaceuticals
(IRWD)
$4.36 none
Perrigo Company plc
(PRGO)
$13.56 none
China Pharma Holdings
(CPHI)
$0.71 none
Ionis Pharmaceuticals
(IONS)
$44.44 none
Inovio Pharmaceuticals
(INO)
$1.24 none

(BMTI)
$0.00 none
Iovance Biotherapeutics
(IOVA)
$10.25 none
Adamis Pharmaceuticals Corporation
(ADMP)
$0.00 none
Novo Nordisk A/S
(NVO)
$43.24 none
Accuray Incorporated
(ARAY)
$0.23 none
TherapeuticsMD
(TXMD)
$2.19 none
Tactile Systems Technology
(TCMD)
$22.20 none
Cerus Corporation
(CERS)
$2.65 none

(EGRX )
$0.25 none

(NBS)
$0.00 none
Biogen
(BIIB)
$215.50 none
Edge Therapeutics
(EDGE)
$51.75 none
Syros Pharmaceuticals
(SYRS)
$0.00 none

(SNTS)
$0.00 none
Amylin Pharmaceuticals
(AMLN)
$0.00 none
Ocuphire Pharma
(OCUP)
$0.00 none
Boston Scientific Corporation
(BSX)
$43.34 none
LifeVantage Corporation
(LFVN)
$6.35 none
BioLineRx Ltd.
(BLRX)
$2.49 none
HCA Healthcare
(HCA)
$427.71 none
DexCom
(DXCM)
$89.35 none
Charles River Laboratories International
(CRL)
$278.06 none
Smith & Nephew plc
(SNN)
$27.56 none
Supernus Pharmaceuticals
(SUPN)
$42.00 none
Intellia Therapeutics
(NTLA)
$12.14 none
BioLife Solutions
(BLFS)
$36.69 none
Cadence Pharmaceuticals
(CADX)
$0.00 none
Rubius Therapeutics
(RUBY)
$0.00 none
ICU Medical
(ICUI)
$152.65 none
EDAP TMS S.A.
(EDAP)
$4.32 none
Nevro Corp.
(NVRO)
$0.00 none
Global X Genomics & Biotechnology ETF
(GNOM)
$66.40 none
MiMedx Group
(MDXG)
$4.77 none
Rocky Mountain Dental Services Holdings, LLC
(BDMS)
$0.00 70%
3M Company
(MMM)
$165.89 none
Sorrento Therapeutics
(SRNE)
$0.00 none
Rocket Pharmaceuticals
(RCKT)
$3.37 none
Ocular Therapeutix
(OCUL)
$9.99 none
Zimmer Biomet Holdings
(ZBH)
$95.36 none
Krystal Biotech
(KRYS)
$336.67 none
Theravance Biopharma
(TBPH)
$17.02 none
Rennova Health
(RNVA)
$0.00 none
Bristol-Myers Squibb Company
(BMY)
$63.06 none
Inspire Medical Systems
(INSP)
$76.78 none
Amarin Corporation plc
(AMRN)
$13.63 none
Universal Health Services
(UHS)
$176.69 none
Corbus Pharmaceuticals Holdings
(CRBP)
$7.48 none
SIGA Technologies
(SIGA)
$3.14 none
Veru
(VERU)
$2.41 none
Calithera Biosciences
(CALA)
$0.00 none
KalVista Pharmaceuticals
(KALV)
$27.00 none
Jaguar Health
(JAGX)
$2.71 none
Savara
(SVRA)
$5.37 none
Novartis AG
(NVS)
$140.37 none
Teva Pharmaceutical Industries Limited
(TEVA)
$38.98 none
NeoGenomics
(NEO)
$19.91 none
Deciphera Pharmaceuticals
(DCPH)
$0.00 none

(BLTI)
$0.00 none

(NUS )
$4.58 87.8%
Pulse Biosciences
(PLSE)
$53.87 none
Teladoc Health
(TDOC)
$6.30 none
Surgery Partners
(SGRY)
$13.25 none
BG Medicine
(BGMD)
$0.00 none
Xencor
(XNCR)
$24.72 none
Anavex Life Sciences Corp.
(AVXL)
$2.42 none
InspireMD
(NSPR)
$0.77 none
Fresenius Medical Care AG & Co. KGaA
(FMS)
$22.20 none
ImmuCell Corporation
(ICCC)
$9.95 none
Alkermes plc
( ALKS)
$43.39 none
Bayer Aktiengesellschaft
(BAYRY)
$13.76 none
Axsome Therapeutics
(AXSM)
$207.78 none
Cara Therapeutics
(CARA)
$0.00 none
Selecta Biosciences
(SELB)
$0.00 none
Medpace Holdings
(MEDP)
$612.33 none
UFP Technologies
(UFPT)
$300.05 none
Agios Pharmaceuticals
(AGIO)
$30.02 none
Phibro Animal Health Corporation
(PAHC)
$36.33 none
Cumberland Pharmaceuticals
(CPIX)
$6.68 none
Tenet Healthcare Corporation
(THC)
$257.62 none

(ABBV )
$250.94 none
Amgen
(AMGN)
$387.64 none
Quest Diagnostics Incorporated
(DGX)
$235.22 none
Escalon Medical Corp.
(ESMC)
$0.18 none
Allogene Therapeutics
(ALLO)
$1.88 none
REGENXBIO
(RGNX)
$9.69 none
Atara Biotherapeutics
(ATRA)
$8.38 none
Butterfly Network
(BFLY)
$7.11 none
Lineage Cell Therapeutics
(BTX)
$8.52 none
Celldex Therapeutics
(CLDX)
$41.06 none
Edwards Lifesciences Corporation
(EW)
$85.76 none
CONMED Corporation
(CNMD)
$46.13 none
Chemed Corporation
(CHE)
$505.97 none
DENTSPLY SIRONA
(XRAY)
$14.20 54.7%
Intuitive Surgical
(ISRG)
$353.10 none
McKesson Corporation
(MCK)
$888.56 none
Alnylam Pharmaceuticals
(ALNY)
$286.62 none
Coherus BioSciences
(CHRS)
$1.23 none
Alphatec Holdings
(ATEC)
$10.15 none
Alimera Sciences
(ALIM)
$0.00 none
Pfizer
(PFE)
$25.15 4.9%
BioTelemetry
(BEAT)
$0.49 none
Acura Pharmaceuticals
(ACUR)
$0.00 none
Abbott Laboratories
(ABT)
$108.00 none
Patterson Companies
(PDCO)
$0.00 none
Anthera Pharmaceuticals
(ANTH)
$0.00 none
Atrion Corporation
(ATRI)
$0.00 none
Ampio Pharmaceuticals
(AMPE)
$0.18 none
DaVita
(DVA)
$240.96 none
Acorda Therapeutics
(ACOR)
$0.00 none
Affymax
(AFFY)
$0.00 none

How to Invest in Healthcare Stocks

Sector-Specific Considerations

When evaluating Healthcare companies, consider these key factors:

  • Sector fundamentals: Is this sector growing, mature, or declining? Growth prospects affect reasonable earnings forecasts.
  • Economic sensitivity: How does this sector perform in different economic conditions? Understanding cyclicality helps you time purchases.
  • Competitive dynamics: Are barriers to entry high or low? Strong moats protect profits and justify premium valuations.
  • Regulatory environment: Does government policy significantly impact this sector? Regulatory changes can create risks or opportunities.
  • Capital intensity: Does the business require heavy capital investment? Capital-light businesses often generate better returns.

✓ Sector Analysis Checklist

  • Compare P/E ratios within the sector
  • Look for strong free cash flow generation
  • Assess debt levels relative to peers
  • Evaluate dividend sustainability
  • Check management track record
  • Calculate margin of safety

Common Sector Pitfalls

  • Chasing last year's hot sector
  • Ignoring sector-wide headwinds
  • Overpaying for market leaders
  • Neglecting competitive threats
  • Failing to diversify across sectors
  • Not understanding the business model